StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for AnaptysBio

AnaptysBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More AnaptysBio figures

See a number that looks wrong?